NasdaqGS - Nasdaq Real Time Price USD

Black Diamond Therapeutics, Inc. (BDTX)

Compare
3.4250 +0.0250 (+0.74%)
As of 12:17 PM EDT. Market Open.

Research Analysis

Earnings Per Share

Consensus EPS
?

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
?

Analyst Price Targets

9.00
14.83 Average
3.4250 Current
20.00 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 7777
Avg. Estimate -0.37-0.35-1.44-1.35
Low Estimate -0.41-0.4-1.54-1.57
High Estimate -0.33-0.31-1.34-0.99
Year Ago EPS -0.45-0.34-1.88-1.44

Revenue Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 7777
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) --------

Earnings History

CURRENCY IN USD 9/30/2023 12/31/2023 3/31/2024 6/30/2024
EPS Est. -0.49-0.47-0.43-0.39
EPS Actual -0.45-0.34-0.35-0.36
Difference 0.040.130.080.03
Surprise % 8.20%27.70%18.60%7.70%

EPS Trend

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Current Estimate -0.37-0.35-1.44-1.35
7 Days Ago -0.37-0.35-1.44-1.36
30 Days Ago -0.35-0.35-1.41-1.54
60 Days Ago -0.35-0.34-1.4-1.54
90 Days Ago -0.37-0.37-1.47-1.67

EPS Revisions

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --113
Up Last 30 Days --224
Down Last 7 Days --------
Down Last 30 Days 222--

Growth Estimates

CURRENCY IN USD BDTXIndustrySectorS&P 500
Current Qtr. 17.80%----4.40%
Next Qtr. -2.90%----7.80%
Current Year 23.40%----2.50%
Next Year 6.20%----13.10%
Next 5 Years (per annum) ------11.89%
Past 5 Years (per annum) --------

Upgrades & Downgrades

Reiterates HC Wainwright & Co.: Buy to Buy 10/9/2024
Reiterates Wedbush: Outperform to Outperform 10/8/2024
Reiterates HC Wainwright & Co.: Buy to Buy 9/24/2024
Maintains Piper Sandler: Overweight to Overweight 9/23/2024
Reiterates HC Wainwright & Co.: Buy to Buy 9/18/2024
Reiterates Wedbush: Outperform to Outperform 9/10/2024

Related Tickers